# Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients

> **NCT01150292** · NA · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 16 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** First period DHA
- **DIETARY_SUPPLEMENT:** Second period DHA

## Key facts

- **NCT ID:** NCT01150292
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150292, "Effects of Docosahexaenoic Acid (DHA) on Cardiovascular Disease on Diabetic Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01150292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*